0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector

RxNorm concept 2640895, clinical drug (scd). Prescribable name: adalimumab-adbm 40 MG in 0.8 ML Auto-Injector.

RxCUI: 2640895
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2640895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

adalimumab 327361

Other names

adalimumab-adbm 40 MG per 0.8 ML Auto-Injector

Related concepts

adalimumab-adbm 50 MG/ML (SCDC, consists of)
{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack (GPCK, contained in)
{6 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack (GPCK, contained in)
Auto-Injector (DF, has dose form)
0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo] (SBD, has tradename)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2640895 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2640895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2640895. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.